4506 — Sumitomo Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapTurnaround

Annual balance sheet for Sumitomo Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	238,580	163,652	36,132	39,956	49,637
Net Total Accounts Receivable
Net Total Receivables	151,500	98,630	97,239	77,726	134,687
Total Inventory
Total Other Current Assets
Total Current Assets	499,521	381,860	269,569	253,168	279,252
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	64,091	58,909	57,895	46,648	44,231
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,308,007	1,134,742	907,506	742,604	804,571
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	278,373	372,694	515,474	240,603	271,500
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	700,119	727,993	751,443	573,125	512,104
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	607,888	406,749	156,063	169,479	292,467
Total Liabilities & Shareholders' Equity	1,308,007	1,134,742	907,506	742,604	804,571
Total Common Shares Outstanding